Documente Academic
Documente Profesional
Documente Cultură
Epidemiology
MEN 1
MEN 1: 11q13 Menin M=F (A.D.) 100% penetrance with
MEN 2
RET: 10 Tyrosine kinase M=F (A.D.) Complete penetrance for
variable expressibility
MTC
Incomplete penetrance with
Genetics
MEN 1
Parathyroid
Most common (98%) endocrine abnormality
Asymmetric, multiglandular parathyroid tumors Milder hypercalcaemia, earlier age of onset
Insulinoma- Neuroglycopenia
Principal cause of mortality
Pituitary
15% to 50%
Prolactinoma- most common Ammenorrhea, galactorrhea, hypogonadism Visual disturbance Acromegaly, Cushings disease
Others
Bronchial or thymic carcinoids
Adrenocortical tumors Lipoma Ependymoma
Diagnosis of MEN 1
Family history Parathyroid
NETs
24hr gastric acid secretion, Secretin test (?)CT/ CT angiography, MRI Endoscpic USG Selective catheterisation of pancreatic artery with Ca gluconate injection
Hormonal assay CT brain
Pituitary
Genetic study
MEN 2
Thyroid
MTC- hallmark of MEN 2
Multifocal, bilateral, young age Secrete Calcitonin, CEA Secretory diarrhea, flushingParaneoplastic syndromes Stridor, upper airway obstruction, hoarseness, dysphagia,
Adrenals
Pheochromocytoma (40% to 50%)
HTN, headache, palpitation, anxiety, tremulousness Malignant HTN, stroke, MI, sudden death Malignant & extra-adrenal pheochromocytomas are
very rare
Parathyroid
10% to 35% patients with MEN 2A
Multiglandular hyperplasia Parathyroid hyperplasia in absence of
Others
MEN 2A
Cutaneous lichen amyloidosis Hirschsprungs disease
MEN 2B
Mucosal neuromas Marfanoid habitus Ganglioneuromas
Megacolon
Diagnosis of MEN 2
Family history MTC
Biopsy Serum Calcitonin, CEA Pentagastrin or Ca challenge test CT neck, spine Diagnostic laparoscopy (?) Annual serum Ca+PTH Annual 24hr urine catecholamine & metanephrine estimation CT/ MRI (>1 cm) Opposed phase chemical- shift MRI I131 MIBG
Parathyroid hyperplasia
Pheochromocytoma
Genetic study
THANK YOU